Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019122 |
---|---|
Receipt number | R000022109 |
Scientific Title | A phase II randomised study to evaluate the efficacy of aprepitant plus palonosetron for preventing delayed-phase CINV associated with TC therapy in gynaecological cancer |
Date of disclosure of the study information | 2015/09/26 |
Last modified on | 2021/03/22 17:24:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/09/26 14:14:02 | ||
2 | Update | 2021/03/22 17:24:41 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Institute Department Organization Organization Division Email1 Organization Organization Address Address Tel |